Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Stanford University
Stanford University
Sumitomo Pharma America, Inc.
H. Lee Moffitt Cancer Center and Research Institute
INSYS Therapeutics Inc
Delcath Systems Inc.
Novartis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Pfizer